Showing results (1-10 of 661) with videos related to
Sort By:
Pageof 67
Alimentary Pharmacology & Therapeutics|June 1, 2019
Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implicationsSaumya Jayakumar, Rohit LoombaCurrent Hepatology Reports|November 1, 2016
Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver DiseaseSaumya Jayakumar, Stephen A Harrison, Rohit LoombaJournal of Hepatology|December 6, 2017
Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directionsRohit LoombaCureus|January 1, 2016
Thrombocytosis in the Setting of Isomerism and a Functionally Univentricular HeartRohit LoombaCanadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|October 10, 2013
Minimal hepatic encephalopathyLaura M Stinton, Saumya JayakumarSeminars in Liver Disease|February 23, 2018
Can Elastography Differentiate Isolated Fatty Liver from Nonalcoholic Steatohepatitis?Veeral Ajmera, Rohit LoombaCurrent Treatment Options in Gastroenterology|March 15, 2021
An update on the role of the microbiome in non-alcoholic fatty liver disease pathogenesis, diagnosis, and treatmentMarialena Mouzaki, Rohit LoombaJournal of Clinical Gastroenterology|December 3, 2019
The Role of Noninvasive Tests for Differentiating NASH From NAFL and Diagnosing Advanced Fibrosis Among Patients With NAFLDMaya Balakrishnan, Rohit LoombaJournal of Clinical and Experimental Hepatology|January 24, 2022
Magnetic Resonance Elastography for the Clinical Risk Assessment of Fibrosis, Cirrhosis, and Portal Hypertension in Patients With NAFLDYamini Natarajan, Rohit LoombaCurrent Hepatology Reports|October 27, 2015
Non-invasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet?Ahilan Arulanandan, Rohit LoombaPageof 67